Sun, P., Wang, Y., Ding, Y., Luo, J., Zhong, J., Xu, N., . . . Xie, W. (2021). Canagliflozin attenuates lipotoxicity in cardiomyocytes and protects diabetic mouse hearts by inhibiting the mTOR/HIF-1α pathway. iScience.
Style de citation ChicagoSun, Pengbo, Yangyang Wang, Yipei Ding, Jingyi Luo, Jin Zhong, Naihan Xu, Yaou Zhang, et Weidong Xie. "Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes and Protects Diabetic Mouse Hearts By Inhibiting the MTOR/HIF-1α Pathway." IScience 2021.
Style de citation MLASun, Pengbo, et al. "Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes and Protects Diabetic Mouse Hearts By Inhibiting the MTOR/HIF-1α Pathway." IScience 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.